VapoCept Reviews: Launches Seven-Ingredient Amino Acid Formula Targeting Focus and Mental Clarity
VapoCept new once-daily capsule system combines L-Arginine, L-Citrulline, and Beta Alanine to support focus, mental
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
VapoCept new once-daily capsule system combines L-Arginine, L-Citrulline, and Beta Alanine to support focus, mental clarity, and everyday energy.
VapoCept new once-daily capsule system combines L-Arginine, L-Citrulline, and Beta Alanine to support focus, mental clarity, and everyday energy
OGDEN, UT – September 3, 2026 – VapoCept today announced the launch of its seven-ingredient amino acid formula for focus and mental clarity. The product is now available directly to consumers through the company’s official website and is distributed by Gex Corporation LLP. VapoCept is formulated as a once-daily vegetable capsule, designed to deliver a seven-ingredient nutritional blend built on a single physiological pathway, with every active amount printed on the Supplement Facts panel.
The cognitive and daily wellness supplement market has seen growth, influenced by consumer awareness of nutritional science and a growing preference for formulations that publish individual ingredient amounts rather than proprietary blends. VapoCept was developed to address a gap in this category: the availability of a single-mechanism formula that discloses each active quantity at the point of purchase. The once-daily capsule format distinguishes the product from powders, stimulant-based pre-workout products, and multi-serving regimens by requiring one capsule per day.
The VapoCept formula comprises seven active ingredients: L-Arginine (base) at 200 mg, L-Arginine AKG 2:1 Extract at 200 mg, L-Citrulline HCl at 100 mg, L-Citrulline Malate at 100 mg, Beta Alanine at 40 mg, Niacin at 7.5 mg NE, and Calcium as calcium carbonate at 18 mg. Each ingredient was selected on the basis of its presence in peer-reviewed nutritional science literature relating to nitric oxide synthesis, cellular energy metabolism, or nervous system function. The formula is stimulant-free, caffeine-free, and free of gelatin, and is delivered in a hypromellose vegetable capsule intended for daily use.
Among the formula’s primary active ingredients, L-Arginine has the longest history of study in nutritional science. A conditionally essential amino acid, it is the direct substrate for nitric oxide synthase, the enzyme that produces nitric oxide in the human body. The Linus Pauling Institute at Oregon State University, through its Micronutrient Information Center, has documented L-Arginine’s role in nitric oxide synthesis and vascular function in adult subjects. L-Citrulline has been the subject of research examining oral bioavailability specifically. A study published in the British Journal of Clinical Pharmacology compared the pharmacokinetic properties of oral L-citrulline and oral L-arginine, documenting that citrulline raises plasma arginine concentrations more efficiently because it is not subject to the same first-pass metabolism in the gut and liver.
For more information, ingredient references, or product details, visit: vapocept.com
L-Citrulline Malate combines citrulline with malic acid, an intermediate in the Krebs cycle involved in cellular energy production. Research published in the Journal of Strength and Conditioning Research has examined citrulline malate in the context of exercise performance in adult subjects. Beta Alanine is the rate-limiting precursor to carnosine, a dipeptide that buffers hydrogen ions in muscle tissue. A meta-analysis published in Amino Acids reviewed beta alanine’s effect on exercise capacity across multiple controlled trials, documenting the most consistent findings in efforts lasting one to four minutes. A separate exploratory study published in PLOS One examined brain carnosine signal and cognitive measures in adult subjects; its authors described that work as exploratory.
Niacin, also identified as vitamin B3, is an essential water-soluble vitamin and a precursor to nicotinamide adenine dinucleotide, a coenzyme central to cellular energy metabolism. The Linus Pauling Institute has documented niacin’s role in energy metabolism and nervous system function in adult populations. The 7.5 mg NE in a VapoCept capsule supplies 47 percent of the Daily Value and sits below the Recommended Dietary Allowance for adults.
Calcium, supplied here as calcium carbonate, is an essential mineral with an established role in nerve signalling, muscle contraction and skeletal health. The National Institutes of Health Office of Dietary Supplements has published reference material documenting calcium’s physiological functions in adult populations. The 18 mg present in VapoCept represents 1.5 percent of the Daily Value and constitutes a small contribution to daily requirements.
The scientific literature referenced above describes independent research conducted on individual ingredients under conditions unaffiliated with Gex Corporation LLP. It does not constitute evidence that VapoCept produces outcomes equivalent to those described in any cited study, and no such equivalence is claimed.
“Nutritional supplementation has historically been an underserved category when it comes to ingredient transparency and dosage disclosure,” said Ryan Davis, Media Relations, VapoCept. “We developed this formula to bring together a set of nutritional compounds with documented literature records in a format that is both practical for daily use and fully disclosed on the label.”
Complete amount disclosure is a central feature of the VapoCept system. Unlike formulations that publish a combined proprietary blend weight, every one of the seven actives in VapoCept is printed on the Supplement Facts panel with its individual milligram quantity, allowing consumers and healthcare providers to compare the formula against the published literature on each compound. The company notes that this approach also supports informed discussion with a physician regarding potential interactions. The product is intended for once-daily use as part of a regular dietary regimen alongside established sleep, diet and activity patterns.
VapoCept is manufactured in the United States in an FDA-registered facility from domestic and internationally sourced ingredients, and is marketed in compliance with applicable U.S. regulations governing dietary supplements. FDA registration is a filing obligation applicable to manufacturing facilities and does not constitute agency evaluation or approval of any product. Statements regarding the product have not been evaluated by the Food and Drug Administration, and the product is not intended to diagnose, treat, cure, or prevent any disease. Because arginine and citrulline are substrates for nitric oxide synthesis, the company recommends that adults taking nitrate medication, antihypertensive medication, or a prescription phosphodiesterase-5 inhibitor consult a qualified healthcare provider before use. The product is not for use by pregnant or nursing mothers or by individuals under 18 years of age, and should be kept out of the reach of children. VapoCept notes that individual results may vary and that the product is designed to complement, not replace, professional medical guidance.
“We believe that consumers evaluating nutritional supplements deserve access to clearly formulated products with every amount published before purchase, delivered in a way that fits into an ordinary daily routine,” the spokesperson added. “VapoCept was built with that standard in mind.”
VapoCept is currently available in multiple supply configurations through the company’s direct-to-consumer platform. All domestic orders are covered by the company’s 60-day money-back guarantee, measured from the date of purchase, with published terms requiring at least 30 days of use before a refund request is submitted. All purchases are one-time transactions with no automatic subscription enrollment. The company has indicated plans to expand its formulation range and explore additional distribution partnerships over the coming fiscal year. For consumers, media representatives, and healthcare professionals seeking additional product information or access to the company’s ingredient reference list, further details are available through the official VapoCept website.
About VapoCept
Founded in 2025, Gex Corporation LLP is a dietary supplement company specializing in single-mechanism nutritional formulations with complete label disclosure. The company’s stated mission is to provide consumers with transparent, clearly dosed nutritional supplements that support their everyday health and wellness goals, and its product range comprises once-daily capsule formulations for adult focus, cognitive support and general daily wellness. The company’s flagship product, VapoCept, is a seven-ingredient once-daily capsule — combining L-Arginine, L-Arginine AKG, L-Citrulline HCl, L-Citrulline Malate, Beta Alanine, Niacin and Calcium — developed for adult daily focus and mental clarity support. Distributed through its direct-to-consumer platform, the company identifies its core values as complete ingredient disclosure on every label, clearly published refund terms, and manufacturing in FDA-registered facilities. For more information, visit vapocept.com.
This press release contains links to a retail partner website through which the distributor may receive compensation if a purchase is made following a referral, disclosed in accordance with the Federal Trade Commission’s guidelines on endorsements and testimonials (16 CFR Part 255). This relationship does not influence the factual content of this release.
Media Contact:
Ryan Davis, Media Relations Manager, Gex Corporation LLP (Founded in 2025)
Email: ryan.davis@vapocept.com (media inquiries)
Email: contact@customercs.com
+1 507-448-8190
PO Box 12730, Ogden, UT 84404, USA
For more press release distribution and guest post services, visit TS Newswire.
